WATERTOWN, Mass., April 05, 2024 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering the development of ...
WATERTOWN, Mass., Oct. 08, 2025 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (Nasdaq: HOWL), pioneering the development of therapeutics engineered to stimulate the ...
PlanMasters GPS President Oscar Aguilar on Thursday morning said a new music festival is coming to West Texas and that entertainers for the event will be announced Friday. The three-day music festival ...
The latest announcement is out from Werewolf Therapeutics (HOWL). Werewolf Therapeutics, Inc. revealed encouraging initial results from their ongoing Phase 1/1b clinical trial of WTX-124, showing ...
Werewolf Therapeutics provided a business update highlighting key milestones for 2025 regarding its clinical development programs. The company is expecting to release data from the Phase 1/1b clinical ...
ODESSA, Texas — The indoor football season kicks off on Saturday when the Warbirds head to Amarillo to face the Venom. West Texas has been revamping its roster and the squad's latest acquisition in ...
PERIO-02: Phase 1b pressure enabled regional immuno-oncology trial of nelitolimod (SD-101), a class C TLR9 agonist, delivered via hepatic artery infusion +/- checkpoint inhibition in intrahepatic ...
MSS Executive Director Autumn Vest speaks about the launch of WTX Nonprofits during an interview Monday at Second Story Coworking in Midland. WTX Nonprofits is a digital nonprofit hub designed to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results